China’s Sinovac Biotech says its third production plant for its COVID-19 vaccine is ready, according to Reuters. The facility has started manufacturing procedures for bulk vaccine ingredient, that doubles annual capacity to 2 billion doses.
The third facility, located in Beijing, had started cultivating cells where the coronavirus would be grown, a procedure that could take a long time.
It is not clear when Sinovac will actually produce 2 billion doses of the vaccine.
At least 200 million doses of Sinovac’s vaccine have been delivered globally, up from 160 million doses announced on March 22.
Sinovac estimates that over 100 million doses of its vaccine have been administered worldwide.
